Translations:Sitagliptin/9/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 20:17, 12 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Sitagliptin)
<!-- Society and culture -->
Sitagliptin was developed by [[Merck & Co.]] and approved for medical use in the United States in 2006. In 2021, it was the 83rd most commonly prescribed medication in the United States, with more than 8{{nbsp}}million prescriptions. It is available as a [[generic medication]] in Canada but not the United States.

Sitagliptin was developed by Merck & Co. and approved for medical use in the United States in 2006. In 2021, it was the 83rd most commonly prescribed medication in the United States, with more than 8 million prescriptions. It is available as a generic medication in Canada but not the United States.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Sitagliptin/9/en&oldid=128337"